Few companies expand their overseas workforce with a global HR strategy in place. Usually the process of going international is incremental, driven by overseas acquisitions, opportunities and new partnerships, rather than a strategic human resources plan. Whether or not you have a formal plan, clear communications with your expanding roster of new employees must be a top priority.
In fact, distributing localized versions of onboarding materials and important internal communications is a legal requirement in many countries — Read more about: How to Maximize Global Employee Engagement and Retention »
The biotech and pharmaceutical industries both work at the cutting edge of science to deliver medical innovations to patients around the world. While the intellectual property portfolios of each industry vary widely, the path to obtaining strong IP protection is similar. To recoup R&D investment, both industries need to file their parents broadly and on a global scale, and that path includes extensive patent translations.
What’s the difference?
Biotech & pharma are often used interchangeably but it’s important to understand the distinction. Read more about: Why a Centralized Translation Source Matters for Biotech and Pharma IP »
Morningside is excited to announce that IQ, the ground-breaking instant quoting feature on our IP Platform is now available for client use.
Designed specifically with our IP clients’ needs in mind, our secure, market-leading IP Platform streamlines and centralizes the patent translation & foreign patent filing process by letting you easily request quotes, place orders and manage IP projects all from one place.
Our newest feature, Read more about: Groundbreaking Instant Quoting Tool for IP Translation & Filing »